[en] The N-terminal fragment of PRL (16K PRL) is an antiangiogenic factor that, in vitro, inhibits several components of angiogenesis including basic fibroblast growth factor (bFGF)-induced cell division, migration, and organization of capillary endothelial cells. An essential step in the regulation of angiogenesis is the activation of urokinase (urokinase type plasminogen activator, uPA), which in turn activates a cascade of proteases that play essential roles in endothelial cell migration and tissue remodeling. Treatment of bovine capillary endothelial cells (BBEC) with 16K PRL inhibited bFGF-stimulated urokinase activity in BBEC as detected by plasminogen substrate gel assay. 16K PRL did not appear to be acting via an effect on uPA expression because no change in messenger RNA levels were observed. However, protein levels of plasminogen activator inhibitor-1 (PAI-1), a specific inhibitor of urokinase, were increased by 16K PRL independent of the action of bFGF. The 16K PRL-induced increase in PAI-1 protein levels appear to be the result of increased expression of the PAI-1 gene. Increased production of PAI-1 induced by 16K PRL results in the formation of inactive PAI-1/uPA complexes, consistent with the observed decrease in uPA activity.
Disciplines :
Biochemistry, biophysics & molecular biology
Author, co-author :
Lee, H.
Struman, Ingrid ; Université de Liège - ULiège > Département des sciences de la vie > GIGA-R : Biologie et génétique moléculaire
Clapp, C.
Martial, Joseph ; Université de Liège - ULiège > Département des sciences de la vie > GIGA-R : Biologie et génétique moléculaire
Weiner, R. I.
Language :
English
Title :
Inhibition of urokinase activity by the antiangiogenic factor 16K prolactin: activation of plasminogen activator inhibitor 1 expression
Folkman J, Klagsburn M 1987 Angiogenic factors. Science 235:442-447
Hanahan D, Folkman J 1996 Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86:353-364
Esch F, Baird A, Ling N, Ueno N, Hill F, Denoroy F, Klepper R, Gospodarowicz D, Bohlen P, Guillemin R 1985 Primary structure of bovine pituitary basic fibroblast growth factor (FGF) and comparison with the amino-terminal sequence of bovine brain acidic FGF. Proc Natl Acad Sci USA 82:6507-6511
Leung DW, Cachianes G, Kuang WJ, Goeddel DV, Ferrara N 1989 Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 246:1306-1309
Felt JW, Strydom DJ, Lobb RR, Alderman EM, Bethune JL, Riordan JF, Vallee BL 1985 Isolation and characterization of angiogenin, an angiogenic protein from human carcinoma cells. Biochemistry 24:5480-5486
Good DJ, Polverini PJ, Rastinejad F, Le Beau MM, Lemons RS, Frazier WA, Bouck NP 1990 A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin. Proc Natl Acad Sci USA 87:6624-6628
Ferrara N, Clapp C, Weiner R 1991 The 16K fragment of prolactin specifically inhibits basal or fibroblast growth factor stimulated growth of capillary endothelial cells. Endocrinology 129:896-900
Sharpe RJ, Byers HR, Scott CF, Bauer SI, Maione TE 1990 Growth inhibition of murine melanoma and human colon carcinoma by recombinant human platelet factor 4. J Natl Cancer Inst 82:848-853
O'Reilly MS, Holmgren L, Shing Y, Chen C, Rosenthal RA, Moses M, Lane WS, Cao Y, Sage EH, Folkman J 1994 Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma [see comments]. Cell 79:315-328
Clapp C, Martial JA, Guzman RC, Rentier-Delure F, Weiner RI 1993 The 16-kilodalton N-terminal fragment of human prolactin is a potent inhibitor of angiogenesis. Endocrinology 133:1292-1299
Saksela O, Rifkin DB 1988 Cell-associated plasminogen activation: regulation and physiological functions. Annu Rev Cell Biol 4:93-126
Dano K, Andreasen PA, Grondahl-Hansen J, Kristensen P, Nielsen LS, Skriver L 1985 Plasminogen activators, tissue degradation, and cancer. Adv Cancer Res 44:139-266
Vassalli JD, Sappino AP, Belin D 1991 The plasminogen activator/plasmin system. J Clin Invest 88:1067-1072
Werb Z, Mainardi CL, Vater CA, Harris Jr E 1977 Endogenous activation of latent collagenase by rheumatoid synovial cells. Evidence for a role of plasminogen activator. N Engl J Med 296:1017-1023
Pepper MS, Vassalli JD, Montesano R, Orci L 1987 Urokinase-type plasminogen activator is induced in migrating capillary endothelial cells. J Cell Biol 105:2535-2541
Odekon LE, Sato Y, Rifkin DB 1992 Urokinase-type plasminogen activator mediates basic fibroblast growth factor-induced bovine endothelial cell migration independent of its proteolytic activity. J Cell Physiol 150:258-263
Fibbi G, Ziehe M, Morbidelli L, Magnelli L, Del Rosso M 1988 Interaction of urokinase with specific receptors stimulates mobilization of bovine adrenal capillary endothelial cells [published erratum appears in Exp Cell Res 1990 Jan;186(1):196]. Exp Cell Res 179:385-395
Pepper MS, Montesano R 1990 Proteolytic balance and capillary morphogenesis. Cell Differ Dev 32:319-327
Laiho M, Saksela O, Andreasen PA, Keski-Oja J 1986 Enhanced production and extracellular deposition of the endothelial-type plasminogen activator inhibitor in cultured human lung fibroblasts by transforming growth factor-beta. J Cell Biol 103:2403-2410
Mimuro J, Schleef RR, Loskutoff DJ 1987 Extracellular matrix of cultured bovine aortic endothelial cells contains functionally active type 1 plasminogen activator inhibitor. Blood 70:721-728
Saksela O, Moscatelli D, Rifkin DB 1987 The opposing effects of basic fibroblast growth factor and transforming growth factor beta on the regulation of plasminogen activator activity in capillary endothelial cells. J Cell Biol 105:957-963
Hekman CM, Loskutoff DJ 1987 Fibrinolytic pathways and the endothelium. Semin Thromb Hemost 13:514-527
D'Angelo G, Struman I, Martial J, Weiner RI 1995 Activation of mitogen-activated protein kinases by vascular endothelial growth factor and basic fibroblast growth factor in capillary endothelial cells is inhibited by the anti-angiogenic factor 16-kDa N-terminal fragment of prolactin. Proc Natl Acad Sci USA 92:6374-6378
Gospodarowicz D, Cheng J 1986 Heparin protects basic and acidic FGF from inactivation. J Cell Physiol 128:475-484
Blei F, Wilson EL, Mignatti P, Rifkin DB 1993 Mechanism of action of angiostatic steroids: suppression of plasminogen activator activity via stimulation of plasminogen activator inhibitor synthesis. J Cell Physiol 155:568-578
Werner S, Duan DS, de Vries C, Peters KG, Johnson DE, William LT 1992 Differential splicing in the extracellular region of fibroblast growth factor receptor 1 generates receptor variants with different ligand-binding specificities. Mol Cell Biol 12:82-88
Moscatelli D 1986 Urokinase-type and tissue-type plasminogen activators have different distributions in cultured bovine capillary endothelial cells. J Cell Biochem 30:19-29
Niiya K, Shinbo M, Ozawa T, Hayakawa Y, Sakuragawa N 1995 Modulation of urokinase-type plasminogen activatorgene expression by inflammatory cytokines in human pre-B lymphoma cell line RC-K8. Thromb Haemost 74:1511-1515
Li J, Croze F, Yan W, Hache RJ, Tsang BK 1997 Up-regulation of urokinase plasminogen activator messenger ribonuleic acid and protein in hen granulosa cells by transforming growth factor alpha in vitro during follicular development. Biol Reprod 56:1317-1322
Manchanda N, Schwartz BS 1995 Interaction of single-chain urokinase and plasminogen activator inhibitor type 1. J Biol Chem 270:20032-20035
Sawdey M, Podor TJ, Loskutoff DJ 1989 Regulation of type 1 plasminogen activator inhibitor gene expression in cultured bovine aortic endothelial cells. Induction by transforming growth factor-beta, lipopolysaccharide, and tumor necrosis factor-alpha. J Biol Chem 264:10396-10401
Pepper MS, Ferrara N, Orci L, Montesano R 1995 Leukemia inhibitory factor (LIF) inhibits angiogenesis in vitro. J Cell Sci 108:73-83
Niedbala MJ, Stein-Picarella M 1992 Tumor necrosis factor regulation of endothelial cell extracellular proteolysis: the role of urokinase plasminogen activator. Biol Chem Hoppe Seyler 373:555-566
Slivka SR, Loskutoff DJ 1991 Regulation of type 1 plasminogen activator inhibitor synthesis by protein kinase C and cAMP in bovine aortic endothelial cells. Biochim Biophys Acta 1094:317-322
Petzelbauer E, Springhorn JP, Tucker AM, Madri JA 1996 Role of plasminogen activator inhibitor in the reciprocal regulation of bovine aortic endothelial and smooth muscle cell migration by TGF-beta 1. Am J Pathol 149:923-931
Madri JA, Bell L, Merwin JR 1992 Modulation of vascular cell behavior by transforming growth factors beta. Mol Reprod Dev 32:121-126